探索高剂量 olanzapine 对治疗耐药精神分裂症青少年的精神病的研究
Shaurya Aggarwal1, Shweta P Sahu1, Puja Shah1
1Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, USA.
Cureus
|October 3, 2025
概括
高剂量 olanzapine 在标准剂量失败时有效治疗了患有治疗耐药精神分裂症的青少年. 这一案例强调了超治疗性 olanzapine 作为耐火精神分裂症青少年的潜在选择.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 治疗耐药精神分裂症带来了挑战,特别是在青少年群体中.
- 关于高剂量 olanzapine 在青少年中有效性的证据有限.
研究的目的:
- 报告一个成功使用超治疗性 olanzapine 治疗青少年治疗耐药精神分裂症的病例.
- 为了贡献关于青少年精神分裂症高剂量 olanzapine 使用的有限文献.
主要方法:
- 一名患有耐治疗精神分裂症的17岁男性接受了口服分解的奥兰扎.
- 剂量逐渐增加到每天50毫克的超治疗水平.
- 监测临床反应和副作用.
主要成果:
- 患者在思维过程,内容和偏执中表现出显著的临床改善.
- 尽管使用了超治疗剂量,但观察到最小的副作用.
- 当paliperidone和标准剂量 olanzapine 失败时,治疗是成功的.
结论:
- 对治疗耐药精神分裂症的青少年来说,超治疗剂量 olanzapine 可能是一个可行的治疗选择.
- 当标准治疗无效或不可行时,可以考虑这种方法,例如当克洛沙平的启动受到阻碍时.
关键词:
青少年精神病是青少年精神病.抗精神病治疗的治疗方法.克洛扎的替代品 克洛扎的替代品高剂量的奥兰扎.口服消解片 消解片口服消解片儿科精神分裂症儿童精神分裂症精神分裂症治疗 治疗精神分裂症第二代抗精神病药物是什么超治疗剂量剂量 超治疗剂量剂量治疗耐药性精神分裂症更多相关视频
11:11Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
254
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
9.3K
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
469
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
469
01:28Psychosis and Antipsychotic Drugs: Overview
816
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
816
01:24Mania and Antimanic Drugs: Overview
549
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
549
01:28Drug Therapy
242
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
242
01:21Antipsychotic Drugs: Typical and Atypical Agents
749
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
749
01:23Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823